A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy
A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy
Not yet recruiting · NCT07572812 · Registry updated 2026-07-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Not yet recruiting | Phase 1 | 2026-07-27 | NCT07572812 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Tiantan Hospital | 307 |
| Shanghai UniXell Biotechnology Co., Ltd | 4 |
| The First Affiliated Hospital of Zhengzhou University | 203 |
| West China Hospital | 359 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tiantan Hospital, Capital Medical University | Beijing | China | 59 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 56 |
| West China School of Medicine and West China Hospital, Sichuan University | Chengdu | China | 1 |